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ABSTRACT
This exploratory work investigates the role of digital media in
expanding health discourse practices in a way to transform
traditional structures of agency in public health. By focusing on a
sample of rare disease patient organisations as representative of
contemporary health activism, this study investigates the role of
digital communication in the development of (1) bottom-up
sharing and co-production of health knowledge, (2) health public
engagement dynamics and (3) health information pathways.
Findings show that digital media affordances for patient
organisations go beyond the provision of social support for
patient communities; they ease one-way, two-way and
crowdsourced processes of health knowledge sharing, exchange
and co-production, provide personalised routes to health public
engagement and bolster the emergence of varied pathways to
health information where experiential knowledge and medical
authority are equally valued. These forms of organisationally
enabled connective action can help the surfacing of personal
narratives that strengthen patient communities, the bottom-up
production of health knowledge relevant to a wider public and
the development of an informational and eventually cultural
context that eases patients’ political action.
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Introduction
The role of digital communication in contemporary mobilisation has become a topical
subject across social movement and media and communication studies. The question
often centres on the level of inﬂuence digital media have on emergence, development
and sustainability of collective action, given different political opportunity structures.
However, the relationship between digital media and health activism, despite the impor-
tance of the impact of health activism on public health services and scientiﬁc research, has
so far remained unexplored.
By drawing upon the ‘logic of connective action’ (Bennett & Segerberg, 2012, 2013), this
study speciﬁcally investigates the affordances of digital communication for patient organ-
isations and it does so by focusing on rare diseases patient organisations.
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The article will review research on health activism with a speciﬁc focus on the role of
patient organisations, and work interested in the relationship between health and digital
media. Then, case study, data and methods will be introduced. The remainder of the
paper will discuss the role of digital media in bottom-up health information sharing, pro-
duction and engagement and in the construction of alternative health information
pathways.
Health activism
In the late 1960s, the women’s health movement began challenging patriarchal norms
embedded in medical stereotypes, framing those norms as detrimental for women’s
health. Twenty years later, AIDS patients advocated for clinical research that could lead
to the discovery of a treatment for their disease and mental health activists marched for
the rights of mentally disabled patients (Brown, Adams, Morello-Frosch, Senier, &
Simpson, 2010, p. 380; Cordner, Brown, & Morello-Frosch, 2014; Epstein, 1995, 1996;
Zoller, 2005, p. 342). In the 1990s, for the ﬁrst time, breast cancer activists drew public
attention to the environmental causes of breast cancer (Brown et al., 2004; McCormick,
Brown, & Zavestoski, 2003; Pezzullo, 2003). These and many other Health Social Move-
ments (HSMs) share a common element: in one way or another, they challenge traditional
conceptions of medical authority.
HSMs advocate for the inclusion of non-scientiﬁc and non-governmental views in the
management of public health, as the ‘scientization of decision-making [… ] can exclude
the public from important policy debates and diminish public capacity to participate in
the production of scientiﬁc knowledge itself’ (Brown & Zavestoski, 2004, p. 681).
Brown and Zavestoski (2004, p. 681) advance that contemporary ‘societal rationalisation’
– or the assumption according to which policy-making has to be primarily informed by
scientiﬁc evidence – foregrounds the role of scientiﬁc expertise by simultaneously down-
playing that of public knowledge. The target of HSMs’ critiques is then often the absent-to-
limited power of patients in the management of public health that is common in tra-
ditional forms of patients’ exclusion from health consultations and in paternalist
approaches to patient involvement (Thompson, 2007). Hence, HSMs hold a twofold
relationship with medicine, on one hand they do depend on medical expertise in the devel-
opment of scientiﬁc research with diagnostic and prognostic objectives but on the other
hand they challenge social, cultural, economic and often politicised dominance of
medical authority in health decision-making.
Drawing upon the American tradition of social movement theory, Brown and col-
leagues provide a typology of HSMs that describes three ideal types: health access move-
ments – that ‘seek equitable access to healthcare and improved provision of healthcare
services’ –, constituency-based health movements – that ‘address health inequality and
health inequity’ across social groups –, and embodied health movements – that ‘address
disease, disability or illness experience by challenging science on aetiology, diagnosis,
treatment and prevention’ (2004, p. 52). Now, while other HSMs categorisations have
perhaps provided more comprehensive explanations of HSMs’ mobilising potentials
(Scambler & Kelleher, 2006) and political orientation (Zoller, 2005), Brown and col-
leagues’ issue-based taxonomy directly focuses both on speciﬁc areas of action and on
the institutional outcomes HSMs try to achieve. In particular, embodied health
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movements (EHMs) are characterised by three elements that make them the most con-
temporary instances of health activism: they introduce the embodied experience of a
disease in activist performances, they directly challenge medical science’s success in
solving health problems that are often ‘socially and economically mediated’ (Brown
et al., 2004, p. 2), and they ease collaborations between patients, patients’ families,
health professionals and lay people via what we may call instances of ﬂuid interaction.
Given that EHMs move the boundaries ‘between what are considered to be patient
skills and initiatives and what remains the responsibility of the doctor’ (Barbot, 2006,
pp. 538–539), they have also been given the attribute of ‘boundary movements’ (Brown
et al., 2004; McCormick et al., 2003). EHMs, as boundary movements, blur traditional dis-
tinctions between lay people and professionals and ‘A central vehicle for blurring these
boundaries is the use of what we term the “citizen/science alliance,” a lay-professional col-
laboration in which citizens and scientists work together on issues identiﬁed by laypeople’
(McCormick et al., 2003, p. 547). In the emergence of these alliances between patients and
health professionals, patient organisations obviously play a pivotal role.
Patient organisations: from auxiliaries to scientiﬁc partners
In EHMs, the traditional division of skills between health professionals and patients – with
the former holding power over medical knowledge and policy access and the latter dealing
with the psychosocial aspects of illness – was overturned when patient organisations
‘joined established actors in the production of medical and scientiﬁc knowledge’
(Barbot, 2006, p. 539). According to this new model, not only did ‘active patients’
(Barbot, 2006) share relevant information on their illness and generated resources for
self-support, they also engaged in the production of scientiﬁc knowledge. In fact, Landze-
lius introduces yet another label for HSMs that directly challenges traditional boundaries
between health professionals and patients, that of ‘“patient organisation movements”: a
label that clearly calls attention to the ﬁgure of the patient, the phenomenon of organis-
ation, and the dynamics of movements’ (2006, p. 530). Landzelius’ work – together
with that of several scholars primarily from the ﬁeld of medical sociology (see, among
the others, Abma, 2006; Barbot, 2006; Caron-Flinterman, Broerse, & Bunders, 2005,
2007; Epstein, 1995, 1996; Rabeharisoa, 2003, 2006; Thompson, 2007) – focuses on the
role of patient organisations in bridging the gap between patients, health professionals
and health policy-makers and in providing the grounds for successful interactions.
While different patient organisations may hold alternative views on patients’ role in the
production of scientiﬁc knowledge (Barbot, 2006, p. 548), instances of patient organis-
ations’ engagement in biomedical research may be categorised under three models: auxili-
ary, emancipatory and partnership (Rabeharisoa, 2003, p. 2128). The auxiliary model
covers a wide range of organisations that, to different degrees, delegate research decisions
to scientiﬁc councils, and limit their ability to decide which research to ﬁnance. In the
most advanced instances of patient organisations’ engagement within this model,
patient organisations work to acquire scientiﬁc knowledge and be able to confront scien-
tiﬁc experts (Epstein, 1995). Traditional patient self-help groups belong here. The eman-
cipatory model emerged as a consequence of the health movements in the 1960s–1970s.
Then, advocacy groups mobilised to engage more directly in decision-making processes,
prioritising their ‘experiential knowledge’ (Borkman, 1976) over traditional forms of
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professional knowledge. The partnership model is particularly relevant to those patient
organisations that advocate for new and/or rare pathologies, where scientiﬁc knowledge
is still scattered, hence those organisations mobilising within EHMs. The role of patient
organisations here is of central importance as ‘(1) the patient organisation is master of
its research policy; and (2) patients are specialists’ partners in their own right’ (Rabehar-
isoa, 2003, p. 2131).
In sum, at the very least, EHM patient organisations work towards the expansion of
discursive space around speciﬁc illnesses and ease interactions among different actors
involved in biomedical research and policy-making relevant to those illnesses. It should,
however, be noted that these communication processes do not happen in a media
vacuum; media ecologies certainly shape discourse dynamics and inﬂuence interaction
processes among different institutional and non-institutional actors.
The digital in health: from eHealth to patients’ digital engagement
The term ‘eHealth’ probably represents the ﬁrst attempt to combine health and Infor-
mation and Communication Technologies (ICTs). In 2001, Eysenbach advanced what
was to become one of the most popular deﬁnitions of eHealth: ‘an emerging ﬁeld in the
intersection of medical informatics, public health and business, referring to health services
and information delivered or enhanced through the Internet and related technologies’
(Eysenbach, 2001, online). In fact, starting from the 1990s, eHealth has received a plethora
of deﬁnitions where technology has been primarily described as a means to expand and
enhance health-related human activities. There, ‘Most commonly, the word health was
used in relation to health services delivery’ (Hans, Carlos, Murray, & Alejandro, 2005,
online). The feeling is that in the 51 different deﬁnitions of eHealth reviewed by Hans
and colleagues (2005), the described technology-enhanced health process is still a top-
down one, where ICTs simply ease the delivery of services from health providers to
health users. Even when exchange processes are described, those processes are usually
not regulated or coordinated by patients or traditional health end users.1 The now emer-
ging literature on mHealth – deﬁned as ‘medical and public health practice supported by
mobile devices’ (World Health Organisation, 2011; quoted in Whittaker, Merry, Dorey, &
Maddison, 2012, p. 12) – applies an approach similar to that of the relationship between
health and (mobile) digital communication, by primarily focusing on the way via mobile
devices ‘information and services can be delivered at appropriate times’ and ‘penetrate into
underserved or disadvantaged populations’ (Whittaker et al., 2012, p. 12, emphasis added).
Traditionally, bottom-up ICTs use for health has been described in research investi-
gating online health information seeking and studies interested in online self-support
groups. The former research strand primarily highlights that users seek health information
online to make health-related decisions, to know about their future and to seek social
support (Balka, Krueger, Holmes, & Stephen, 2010). This work also draws attention to
health digital divide issues (Wyatt, Henwood, & Hart, 2005), especially social inequalities
in technology access (Gustafson et al., 2005; Hsu et al., 2005), literacy skills (Mackert,
Champlin, Holton, Muñoz, & Damásio, 2014; Zarcadoolas, Blanco, Boyer, & Pleasant,
2002) and information-ﬁltering skills (Eysenbach & Kohler, 2002).
Studies interested in online self-support groups investigate the impact of such groups
on patients and patients’ relatives, particularly on the emotional aspects of living with a
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disease. Research in this camp has measured the relationship between type of illness and
the likelihood for a patient to use online groups of support (Owen et al., 2010) or inves-
tigated the importance of online tie support (Cohen & Raymond, 2011; Wright, Rains, &
Banas, 2010). Health information seeking and online social support research strands are
now merging in studies interested in patients’ use of undifferentiated social media (e.g.,
Facebook) (Greene, Choudhry, Kilabuk, & Shrank, 2011) and specialised social media
(e.g., PatientsLikeMe) (Kallinikos & Tempini, 2014; Tempini, 2015) to seek, produce
and share personal health data.
An element that is still highly overlooked in research concerned with the bottom-up use
of digital media in relation to health is how patients organisations exploit digital affor-
dances in their advocacy and activist action, namely, in expanding health discourse prac-
tices and mobilising and connecting different publics.
The logic of connective action
In her work on collective mobilisation on muscular dystrophy, Rabeharisoa (2006) shows
how not only do patient organisations act as patients’ representatives; in their mobilising
for ‘the cure’ and for patients’ recognition, they often work as mediators among different
social actors and across different social spaces. But how do contemporary digital media
contribute to such processes of mediation and mobilisation?
The most contemporary literature interested in the relationship between media and
mobilisation focuses exactly on the extent to which digital media can change traditional
dynamics of social contention, especially in conditions of poor or limited resources.
The point at stake here is that for the formation of collective actors and the diffusion of
collective action frames, a certain amount of resources is needed, in terms of organis-
ational support, communication strategy and formal membership dynamics. The most
popular explanation of the role of digital media in contemporary protest is that they
may become resources themselves and cover for most of the mobilisation processes that
traditionally had high costs (Bennett, 2003). This explanation implies that digital media
do not change the dynamics of collective action; they simply ease its emergence where
resources are limited.
However, recent instances of mobilisation have shown what have been deﬁned as ‘ﬂuid’
forms of mobilisation (Gerbaudo, 2012), where traditional dynamics of collective action –
like the emergence of a collective actor with deﬁned leaders and claims and clearly sup-
ported by institutional organisations – seem to be less evident than in the past. In these
instances of mobilisation, individuals – free from organisational ties and detached from
strongly deﬁned ideological claims – connect and disconnect more ﬂuidly. Social network-
ing has been described as at the centre of these dynamics of engagement: ‘when people
who seek more personalised paths to concerted action are familiar with practices of
social networking in everyday life [… ], they are already familiar with a different logic
of organisation: the logic of connective action’ (Bennett & Segerberg, 2013, p. 29). The
idea is that digital media can replace traditional organisations, allowing the emergence
of activism based on personal – rather than collective – frames of action shared on tech-
nological platforms. In the realm of ‘connective action’, traditional organisations are either
absent or only responsible for a loose coordination of action. Bennett and Segerberg (2013)
distinguish between the forms of mobilisation derived from these two different
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organisational settings, calling them ‘crowd-enabled’ and ‘organisationally enabled’ con-
nective action, respectively. According to Bennett and Segerberg, ‘digitally networking
mechanisms’ – from web links to website organisational devices like calendars and infor-
mation sharing tools – ‘help calibrate relationships by establishing levels of transparency,
privacy, security, and interpersonal trust’ (2012, p. 753). As such, digitally networking
mechanisms may offer different routes to engagement where Dahlgren’s parameters of
public engagement – intensity, depth, disposition, mode, ﬁeld, socio-cultural origins
and maintenance (2015) – can vary considerably.
By drawing upon the logic of connective action, the study tackles the question of how
digital communication contributes to – and possibly shapes –EHM activism.
Case study: rare disease patient organisations
A disease is deﬁned rare when it affects 1 in 2000 people in the European Community and
1 in 1250 people in the USA. Most of the over 6000 rare diseases so far identiﬁed are
chronic and life-threatening (Eurordis, 2015; Nord, 2015). Rare disease patients face extre-
mely adverse conditions primarily because of the lack of information and knowledge on
their disease in both the medical community and the general public. As Brown and Zaves-
tosky suggest:
When a condition has no name, or a name that does not receive medical legitimacy, the for-
mation of illness identities, and thus a politicised identity, is constrained. Also, even if people
with such a condition succeed in developing a politicised collective illness identity, they have
a much more difﬁcult time generating scientiﬁc knowledge. (2004, p. 74)
As a matter of fact, until the 1980s the pharmaceutical industry neglected rare disease
research because it considered it not proﬁtable. The situation changed, thanks to lobbying
by the rare disease community that advocated for the implementation of speciﬁc policy to
ease the development of treatments for rare diseases (Aymé, Kole, & Graft, 2008).
Given that the ﬁrst obstacle to public and private intervention in the case of rare dis-
eases is the limited number of patients affected by each individual disease, patient organ-
isations have started networking across patient communities, drawing attention to the
overall impact of rare diseases. In fact, on the websites of the major umbrella organisations
for rare diseases in the EU and the USA, one reads: ‘An individual rare disease may affect
only one person in a million, but all together, rare disease patients comprise 6% to 8% of
the EU population’ (Eurordis, 2015). ‘While each [rare] disease is rare, when considered
together they affect nearly 30 million Americans or almost 1 in 10 people’ (NORD, 2015).
Therefore, rare disease patient communities are working towards building a rare disease
‘solidarity network’ (Rogers, 2004), to both generate support for rare disease patients
and raise awareness in the general public.
Rare disease patient organisations are representative of EHMs because they often focus
on the embodied experience of a disease, challenge existing – or non-existing – medical
knowledge, and pursue partnerships between patients, patients’ families, health pro-
fessionals, health policy-makers and lay people. Also, given the lack of knowledge and
expertise in rare disease diagnosis and treatment, patient organisations usually follow a
partnership model of engagement in biomedical research (Aymé et al., 2008; Barbot,
2006; Rabeharisoa, 2003). Finally, rare disease patients and patients’ families have been
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deﬁned as extremely active in searching and exchanging online health information (Fox,
2011).
Taking rare disease patient organisations as a case study, this research aims to investi-
gate how digital mechanisms shape EHM activism. This goal is driven by three speciﬁc
questions:
RQ1: How do EHM patient organisations exploit digital mechanisms for bottom-up
sharing and co-production of health knowledge on speciﬁc issues (e.g., a rare
disease)?
RQ2: How do EHM patient organisations exploit digital mechanisms to generate public
engagement?
RQ3: To what extent do EHM patient organisations exploit online linking to endorse
varied health information pathways?
Data, sample and methods
This study is exploratory in nature. It speciﬁcally focuses on the websites of rare disease
patient organisations as websites are usually the ‘most public of faces’ for activist organ-
isations (Bennett & Segerberg, 2013, p. 60). The analytical procedure applied here is
similar to Mager’s (2009) sociotechnical approach to provision and use of online health
information. In particular, we investigate websites’ digital mechanisms (i.e., various
more or less interactive website elements) as what Bennett and Segerberg deﬁne ‘potential
network agents alongside human actors (i.e. individuals and organisations)’ (2012, p. 753).
In fact, the study’s goals required an analytical design where online content and content
connectors could be identiﬁed, categorised and mapped.
The investigation focuses on a purposive sample of 31 rare disease patient organisations
designed in August 2013. A list of rare diseases was initially generated on the basis of the
most recent approvals for rare disease treatments by the EU and US regulatory authorities
(i.e., European Medicine Agency (EMA) and Food and Drug Administration (FDA),
respectively). This was meant to provide relevant information on active rare disease
patient communities advocating for treatment research. Then, the name of each retrieved
disease was searched on google.com to identify the online top-ranked organisations advo-
cating for that disease, so to isolate the relevant patient organisations that were strategi-
cally exploiting online information politics (Mager, 2009, pp. 1127–1129). When the
websites of patient organisations from different countries appeared in the list of the
ﬁrst 10 retrieved webpages, all organisations were included in the sample. Table 1 provides
details of the study’s sample.
The ﬁrst analytical step was functional to address RQ1 and RQ2 and as such comprised
the investigation of the websites’ digital mechanisms speciﬁcally meant to disseminate
patients’ health knowledge (RQ1) and provide elements for public engagement (RQ2).2
In this phase, the authors conducted a preliminary sample screening to familiarise with
the data and operationalise a codebook for data collection. Then, a ﬁrst coder conducted
data collection and a second coder carried out data cleaning and input versus output ver-
iﬁcation, namely, she tested consistency between gathered information and codes’ deﬁ-
nitions (Freeman, 2004, p. 78).3
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The second analytical phase comprised the investigation of the organisations’ online
links to other entities. In fact, Rogers’ (2013) approach to online linking strategies was
applied to interpret how and to what extent patient organisations exploit online network-
ing structures to provide alternative informational pathways around health issues (RQ3).
Analysis
Patient-generated health knowledge and routes to health public engagement
The coding process provided evidence that patient organisations use a wide range of
online elements to inform and engage different publics. Ready-made informative elements
are the most traditional items, turning websites into repositories of information. Diagnos-
tic information may range from descriptions of symptoms to information on inheritance
patterns, on to information on disease causes, details on patients’ life expectancy, patients’
Table 1. Sample: rare diseases and patient organisations.
Rare disease Patient organisation Location Website address
Addison’s disease Addison’s Disease Self Help Group UK www.addisons.org.uk
Amyloidosis Amyloidosis Foundation USA www.amyloidosis.org
Ataxia Ataxia UK UK www.ataxia.org.uk
Blood cancer Leukaemia &Lymphoma research UK leukaemialymphomaresearch.
org.uk
Childhood auto Inﬂammatory
disease
Stop CAID Now USA www.stopcaidnow.org
Childhood cancer Children with Cancer UK UK www.childrenwithcancer.org.uk
Chronic lymphocytic leukaemia (CLL) CLL Support Association UK www.cllsupport.org.uk
Chronic Myelogenous Leukaemia
(CML)
The National CML Society UK www.nationalcmlsociety.org
Cryopyrin-associated periodic
syndromes (CAPS)
Nomid Alliance USA www.nomidalliance.org
Cystic ﬁbrosis Cystic Fibrosis Trust UK www.cysticﬁbrosis.org.uk
Cystic ﬁbrosis Cystic Fibrosis Canada Canada www.cysticﬁbrosis.ca
Cystic ﬁbrosis Cystic Fibrosis Foundation USA www.cff.org
Friedreich’s ataxia FARA USA www.curefa.org
Gaucher disease Gaucher Association UK www.gaucher.org.uk
Gaucher disease National Gaucher Foundation, Inc. USA www.gaucherdisease.org
Hereditary angioedema US Hereditary Angioedema
Association (HAEA)
USA www.haea.org
Hereditary angioedema HAEUK UK www.haeuk.org
Idiopathic pulmonary ﬁbrosis Pulmonary Fibrosis Foundation USA www.pulmonaryﬁbrosis.org
Leukaemia Leukaemia Foundation Australia www.leukaemia.org.au
Lymphoma Lymphoma Research Foundation USA www.lymphoma.org
Lynch syndrome Lynch Syndrome International USA www.lynchcancers.com/
Multiple myeloma Multiple Myeloma Research
Foundation
USA www.themmrf.org
Myeloma International Myeloma
Foundation
USA myeloma.org
Myeloma Myeloma UK UK www.myeloma.org.uk
Myeloproliferative neoplasms MPN Research Foundation USA www.mpnresearchfoundation.
org
Pituitary disease The Pituitary Society USA www.pituitarysociety.org
Pulmonary ﬁbrosis Coalition for Pulmonary Fibrosis USA www.coalitionforpf.org
Short bowel syndrome Short Bowel Support (SBS) USA www.shortbowelsupport.com
ShortbBowel syndrome Short Bowel Syndrome
Foundation
USA www.shortbowelfoundation.org
Tuberous sclerosis Tuberous Sclerosis Alliance USA http://www.tsalliance.org
Tuberous sclerosis Tuberous Sclerosis Association UK http://www.tuberous-sclerosis.
org
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testimonies on symptoms, list of relevant scientiﬁc publications, information on diagnostic
centres, expert answers and FAQ sections. Treatment is usually covered by providing
information on existing cures, general data on clinical trials, patients’ testimonies on treat-
ments and clinical trials, lists of scientiﬁc publications, expert answers and information on
support centres. Overall, these elements provide contextual information that could be of
use and support for patients, patients’ relatives, lay people and GPs willing to know more
on a speciﬁc disease. Details on the presence of a patients’ registry are also often a key piece
of information, especially to know whether a patients’ database is available for future clini-
cal trials.
These central informative elements, primarily used to ground the most relevant data
available on a disease, are often coupled with more dynamic elements like organisational
devices as calendars and news sections where the organisation presents future activities,
video material on YouTube and/or Vimeo and social media feeds (e.g., RSS, Facebook,
Twitter). Overall, this ﬁrst set of digital mechanisms does not constitute more than a
list of one-way information channels, where end users are given the opportunity to
browse more or less basic information on the disease at stake and, as such, given the
chance to engage in knowledge acquisition rather than in any real form of action.
These elements belong to the pool of digital mechanisms where ‘information can be
observed moving in largely one-way ﬂows from an organisation to its publics (e.g. via
newsletters, closed calendars)’ (Bennett & Segerberg, 2013, p. 137).
A second set of digital mechanisms is of those where end users are given the option to
access further one-way information channels. The analysis showed two similar mechan-
isms of this type used in different websites: newsletter registration and email update regis-
tration. These items add an action element to the ﬁrst list of digital mechanisms as they
require the end user to take minimal action to access further information. These elements
build a loose tie between the organisation and the end user as the latter, upon registration,
will start receiving messages from the former.
When engaging with the third set of digital mechanisms, the end user is given the
option to contact the organisation and start a real information exchange. These items
add a collaborative element between the end user and the organisation as they enhance
communication processes that ‘can emerge through interactive information sharing’
(Bennett & Segerberg, 2013, p. 137). This may happen via Contact us or Registration/
log in forms or via a more or less direct involvement with the organisation’s activity as
the end user may directly donate money or purchase merchandise to indirectly participate
in the organisation’s fundraising. In these cases the end user, if taking the action, shares
more of her personal sphere with the organisation and engages in a more or less developed
exchange of information with it.
While the ﬁrst three sets of digital mechanisms enhance one-way or two-way com-
munication processes, the very last group of digital mechanisms is that of digitally net-
working mechanisms. Here the end user is given the possibility to engage in
crowdsourced communication processes. This could happen in different ways: on the
one hand, the end user can engage in websites’ internal forums, chats or blogs or share
material like videos or photos. On the other hand, website links can lead to external
social media platforms: there, the end user can follow the organisation’s Facebook page
or join its Facebook group, join the organisation’s circle on Google+, follow the organis-
ation on Flickr or Twitter, link to the organisation’s LinkedIn page, join mailing lists, share
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or bookmark the organisation’s website address or access forums, chats or blogs. These
action opportunities are highly unstructured, that is, the organisation may gradually
move to the background of the communication process, with different publics connecting
and engaging in health personal knowledge sharing and co-production.
Now, a way to interpret these four different models of health knowledge transition (i.e.,
one-way communication processes) or exchange (two-way or crowdsourced communi-
cation processes) is by looking at the form of engagement they require. To measure the
deriving engagement models, we can draw upon two of Dahlgren’s (2015) parameters
of engagement: ‘intensity’ and ‘depth’. The ﬁrst parameter translates as the degree of
agency exerted by the end user in engaging in the issue at stake. Looked at through this
prism, public engagement eased by digital mechanisms varies from one where individuals
exert very limited agency and only engage in increasing their personal health knowledge to
one where different publics potentially get involved in active discussions on health,
exchanging their experiential knowledge. Evaluating the depth of engagement means
measuring ‘howmuch of the self is involved’ (Dahlgren, 2015). As shown in Figure 1, start-
ing from the second set of the digital mechanisms described above, end users are required
to partially become public and share some of their personal information, with the organ-
isation in the second and third sets of digital mechanisms, and with different publics in
digitally networking mechanisms.
Figure 1. Digital mechanisms on the websites of rare disease patient organisations.
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In sum, digital mechanisms on rare disease patient organisation websites provide at
least four different types of communication processes where bottom-up selected and/or
generated health knowledge is delivered to the end user, exchanged between the patient
organisation and end user or crowdsourced by different end users and possibly – but
not necessarily – by the patient organisation. These different channels for health knowl-
edge transition and exchange generate different dimensions of public engagement
where intensity and depth – or agency and publicity – can vary considerably.
Health information pathways
Not only do digital mechanisms ease sharing and co-production of health knowledge via
offering different routes to engagement. By exploiting hyperlinking structures, they also
ease online bridging among different social actors and bolster the development of
health information pathways.
By using Issuecrawler software for online crawling, we tracked the outlinks of our
sample organisations. The crawler was set to use a snowball crawling method, namely
to crawl seeds [i.e., sample websites] and retain URLs with at least one link from those
seeds. The crawling was set at depth 2, which means that the results reported the webpages
linked to in the sample’s homepages and in the homepages’ internally linked webpages.
Figure 2. Sample snowball 1st degree network (network crawl by issuecrawler.net, courtesy of the
Govcom Foundation).
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Figure 2 shows the derived network, where red nodes represent the sample organisation
websites and all the other nodes stand for websites they link to. Green shading and
node size measure in-degree Freeman centrality, or the number of links received by a
website: bigger and darker the colour, higher the in-degree value.4 Now, this network is
populated by 3971, with 410 websites being linked to by more than one sample website.
In fact, Figure 2 shows that in the derived network 30 of our 31 sample websites link to
other entities, some of which, namely those 410 websites, are in more (in-degree)
central positions than others.
Nodes range from other patient organisations, umbrella networks of patient organis-
ations, websites of national health services, public and private research centres, private
companies offering patients’ assistance, biomedical sources of information, news outlets
and social media platforms of different types. This indicates that patient organisations
do not so much use online linking affordances to create coalitions of patient organisations,
or solidarity networks (Rogers, 2004), around patient communities but rather to redirect
end users to a wide range of social actors and information sources more or less directly
involved in the health issue they mobilise for.
Now, taking Freeman centrality as a network measure of node power, those websites
receiving links from more than one of the sample websites can be considered as inﬂuential
in the derived network. In order to focus more speciﬁcally on these central nodes, we ran a
co-link crawling, one where the ‘crawl seeds and retain URLs with at least two links from
seeds’ (Issuecrawler.net, 2015). With the crawler being set again at depth 2, the derived
network (Figure 3) is only populated by 30 sample websites and the 410 websites whose
Figure 3. Sample co-links network (network crawl by issuecrawler.net, courtesy of the Govcom
Foundation).
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absolute in-degree centrality was equal to or bigger than 2. Hence, from the perspective of
website end users, Figure 3 shows the most likely online informational pathways origi-
nated by rare disease patient organisation websites.
Table 2 shows the network nodes that receive links from six or more of the sample
organisation websites.
The most evident consideration to be drawn here is that social media are more central
to the network than any other online source of information or site for action. More speciﬁ-
cally, Facebook is linked by 23 of the sample organisations, directly followed by YouTube
with 20 links and Twitter just three positions down in the ranking with 17 links. It is cer-
tainly interesting to notice that Facebook and YouTube are sources of information slightly
more likely to be linked than institutional entities such as ClinicalTrials.gov (global regis-
try of clinical studies) and ncbi.nlm.nih.gov (repository of biomedical and genomic infor-
mation) and deﬁnitely more popular than international patient organisations like
raredisease.org (NORD, US Umbrella network of rare disease patient organisations). In
other words, it is more common for rare disease patient organisations to redirect end
users to platforms where information is shared and co-produced by different actors in
individualised processes of crowdsourced communication rather than to entities represen-
tative of scientiﬁc knowledge or institutionalised advocacy.
In sum, these results suggest that online digital networking mechanisms ease the devel-
opment of information pathways that neither develop around clusters of patient organis-
ations nor exclusively centralise on traditional authoritative sources of biomedical
Table 2. Most central (in-degree) nodes.
Label Site type Absolute in-degree value
facebook.com Social medium 23
youtube.com Social medium 20
clinicaltrials.gov World registry of clinical studies 19
ncbi.nlm.nih.gov Repository of biomedical and genomic information 17
twitter.com Social medium 17
fda.gov (USA) Regulatory authority for drug administration 11
cancer.gov (USA) Centre for cancer research 10
nature.com Scientiﬁc publication 10
nih.gov (USA) Medical research agency 10
linkedin.com Social medium 9
nlm.nih.gov (USA) Library of medicine 9
rarediseases.org (USA) Umbrella network of rare disease patient organisations 9
onlinelibrary.wiley.com Online library 8
en.wikipedia.org Collaborative online encyclopaedia 7
geneticalliance.org World umbrella network of rare disease patient organisations 7
justgiving.com Social medium for fundraising 7
uk.virginmoneygiving.com Social medium for fundraising 7
caringbridge.org (USA) Charity for patients’ support 6
cdc.gov (USA) Centre for disease control and prevention 6
inspire.com Social medium for patient communities 6
lls.org World health organisation 6
mayoclinic.com (USA) Medical care and Research Centre 6
medicare.gov (USA) National health insurance 6
medscape.com Scientiﬁc publication 6
nejm.org Scientiﬁc publication 6
nhs.uk (UK) National health service 6
nytimes.com (USA) News outlet 6
patientadvocate.org (USA) Charity for patients’ support 6
patienttravel.org (USA) Charity for patients’ support 6
rarediseases.info.nih.gov (USA) Centre for rare disease research 6
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information representative of scientiﬁc knowledge and medical authority. In fact, EHM
patient organisations develop online health information pathways that often privilege
crowdsourced processes of knowledge production and exchange (i.e., digitally networking
mechanisms in Table 1) over information-seeking processes targeted at traditional scien-
tiﬁc sources and advocacy actors.
Discussion and conclusion
In their work on collective action in contemporary media ecologies, Bimber, Flanagin and
Stohl write:
one of the chief obstacles to human interaction is informational: the discovery of shared
interests, shared desires, or common experiences and acquaintances. Technologies that
help people identify and overcome these information and communication obstacles can
readily facilitate the beginnings of social behaviour. (2005, p. 382)
Our study focuses exactly on the ways digital communication helps EHMs – where
patient organisations are most likely to seek partnership roles with the medical community
and health policy-makers – overcome informational obstacles among patients and
between patients and other actors, ease the emergence and dissemination of patient-gen-
erated health knowledge and provide the informational and eventually cultural context for
bottom-up agency around health issues.
The analysis shows that the digital mechanisms used in EHM patient organisation web-
sites generate different dynamics for health knowledge sharing (one-way communication
processes), exchange (two-way communication processes) and co-production (crowd-
sourced communication processes), where individuals can engage in different forms of
health activism. In fact, digital mechanisms blur the traditional boundary between
private and public domains and allow the development of forms of engagement that are
less personally bonding than in traditional practices ofpublic engagement. Even in the
most public form of engagement, that eased by digitally networking mechanisms, the
website end user is allowed to form loose ties both with the organisation and with
other end users. By allowing greater individual control over how to engage with a
health issue, digital communication enhanced by these organisations eases the emergence
of individualised identiﬁcations that can be more inclusive than traditional collective
framing of health activism. It also increases the potential for personal networks to play
a central role in health activism. We may rename these dynamics as of ‘intraconnectivity’
as they help bonding dynamics (Putnam, 2000) in easing emergence, development and
consolidation of the illness identity (Brown & Zavestoski, 2004) of a patient community.
Seen from the lenses of health activism, this implies that not only do digital communi-
cation in general, and digitally networking mechanisms in particular, ease online health-
information-seeking processes (Balka et al., 2010) and the provision and use of health
information (Mager, 2009). They also offer the context for patient organisations to
form loosely networked publics that produce crowdsourced health knowledge via
‘second-order commonality’ processes (Bimber, Flanagin, & Stohl, 2005, p. 372). In
other words, individuals – by for instance participating in Facebook group discussions
or Twitter hashtagged streams – can contribute to health knowledge repositories ‘with
only partial knowledge of other participants or contributors and without a clear intention
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or knowledge of contributing to communal information with public goods properties’
(Bimber et al., 2005, p. 372). Hence, personal narratives of illness can connect online
and, while certainly providing social support (Eysenbach, Powell, Englesakis, Rizo, &
Stern, 2004) to the members of a speciﬁc patient community, they can also add elements
to health knowledge relevant to that community and to a wider public.
Not only does digital networking ease interactions between individuals and patient
organisations and among individuals, it also enacts the development of health information
pathways speciﬁcally endorsed by patient organisations. The website crawling exercise
showed that hyperlinking features on EHM patient organisation websites redirect end
users towards a heterogeneous range of informational sources, from the websites of
other patient organisations, to those of public health institutions, private companies,
scientiﬁc journals and media outlets. Within this variety, umbrella patient organisations
are not extremely popular. This means that hyperlinking strategies do not have ‘aspira-
tional’ (Rogers, 2013, p. 45) goals, that is, they do not reproduce hierarchical structures
and do not represent a desire of afﬁliation with established, institutionalised actors. More-
over, pages, groups or discussion threads on social media platforms are often more linked
than traditional scientiﬁc resources. On the one hand, the end user is most likely to be
redirected to crowdsourced platforms of communication where the level of moderation
by the patient organisation can highly vary. In fact, the organisation’s institutional pres-
ence may be totally backgrounded to free space for decentralised interactions among
end users. This suggests the possibility of a ﬂuid coexistence of ‘organisationally
enabled’ and ‘crowd-enabled’ (Bennett & Segerberg, 2013) health connective action,
with individuals moving from one form of action to the other (and possibly vice versa).
This also suggests that a strategic participation of health professionals and health care pro-
viders5 – but also regulators and policy-makers6 – in digitally networking processes (e.g.,
on social media platforms) would probably further ease crowdsourced processes of health
knowledge construction, especially in the case of controversial or unresolved health issues
(e.g., rare diseases).
On the other hand, links to traditional scientiﬁc resources allow the emergence of
‘boundary’ (Brown & Zavestoski, 2004) informational nodes that ease interconnectivity,
that is, connectivity across patient communities. Most rare disease patient organisations,
for instance, advocate for genetic testing and drug development, hence data on genomic
information (e.g., ncbi.nlm.nih.gov) and clinical trials (e.g., clinicaltrials.gov) are central
across rare disease patient communities. In other words, hyperlinking dynamics ease
the emergence of informational nodes that are boundary – ‘objects that overlap different
social worlds and are malleable enough to be used by different parties’ (Brown & Zaves-
toski, 2004, p. 63), for example, different patient groups, the biomedical community, the
pharmaceutical industry and health policy-makers. In this sense, hyperlinking dynamics
have bridging potential (Putnam, 2000).
In sum, this study shows that digital media are shaping EHMs – namely the most con-
temporary examples of health activism – in ‘organisationally enabled networks’ where
‘constituent organisations adopt the signature mode of personalising the engagement of
publics. In particular, this means deploying discourses and interactive media that offer
greater choice over how people may engage’ (Bennett & Segerberg, 2013, p. 48). Digital
mechanisms are helping EHM patient organisations expand discursive space, create differ-
ent dimensions of public engagement and generate informational pathways where
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patients’ experiential knowledge and scientiﬁc information are equally valued. In particu-
lar, by favouring processes of crowdsourced knowledge production and exchange, digitally
networking mechanisms (e.g., Facebook pages or groups, Google+ circles, Twitter
accounts or Twitter hashtagged streams) can ease the emergence of personal narratives
of illness that become central to generate and strengthen ties within a patient community,
produce, share and disseminate patient-generated health epistemic knowledge and create
the context for patients’ health political action.
Finally, also given that rare disease patient organisations have been deﬁned as ‘among
the most empowered groups in the health sector’ (Aymé et al., 2008, p. 2050), the ‘connec-
tive action’ uncovered in the present study may prove relevant to other patient commu-
nities struggling to mobilise in the public arena.
Notes
1. For an update of the discussion on the deﬁnition of eHealth, see Boogerd, Arts, Engelen, and
van de Belt (2015).
2. Notice that, differently from Bennett and Segerberg (2012, 2013), we use the term “digital
mechanism” to indicate any website element used to share information and the term “digi-
tally networking mechanism” to speciﬁcally label digital mechanisms that enable networking
dynamics.
3. This study is part of a bigger project that looks at different functionalities of rare disease
patient organisation websites. The codebook was used to collect data relevant to the whole
project and was designed in the form of a questionnaire with open-ended and close-ended
questions. The questionnaire is available at: https://docs.google.com/forms/d/1XSeRxNX
pBrIuMqChNA1WtJjjmwRHoydyiwrmP4rDuPQ/viewform. The codebook’s part mostly
relevant to the present study was informed by both the authors’ initial sample screening
and Bennett and Segerberg’s (2013, p. 136–138) categorisation of “digital networking
mechanisms”.
4. In asymmetric networks, Freeman centrality measures the number of incoming (indegree)
and outgoing (outdegree) ties for each single node (Franzosi, 1979).
5. On the engagement of health professional in social media platforms see, for instance, Varta-
bedian (2015).
6. EMA and FDA have been enhancing the direct involvement of patients in their activities – for
example, inviting patient representatives to participate as panellists in public meetings on
drug evaluation – for a few years now (Terry & Patrick-Lake, 2015). The question here is
then on how such collaborations could be further eased via digital networking mechanisms.
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